1. Home
  2. EQBK vs CTY Comparison

EQBK vs CTY Comparison

Compare EQBK & CTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

N/A

Current Price

$48.07

Market Cap

982.9M

Sector

Finance

ML Signal

N/A

CTY

City Therapeutics Inc. Common Stock

N/A

Current Price

$17.55

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQBK
CTY
Founded
2002
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.9M
1.0B
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
EQBK
CTY
Price
$48.07
$17.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
★ $54.14
$37.33
AVG Volume (30 Days)
87.2K
★ 250.4K
Earning Date
10-14-2026
12-01-2026
Dividend Yield
★ 1.82%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.35
N/A
Revenue
N/A
N/A
Revenue This Year
$29.42
$62.96
Revenue Next Year
$21.36
$7.47
P/E Ratio
$14.41
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.50
$15.81
52 Week High
$52.27
$22.65

Technical Indicators

Market Signals
Indicator
EQBK
CTY
Relative Strength Index (RSI) 44.16 41.04
Support Level $46.25 $16.12
Resistance Level $51.78 $21.98
Average True Range (ATR) 1.00 2.35
MACD -0.11 -0.15
Stochastic Oscillator 7.45 25.44

Price Performance

Historical Comparison
EQBK
CTY

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About CTY City Therapeutics Inc. Common Stock

City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.

Share on Social Networks: